Treatment-independent miRNA signature in blood of Wilms tumor patients.

Abstract

BACKGROUND:

Blood-born miRNA signatures have recently been reported for various tumor diseases. Here, we compared the miRNA signature in Wilms tumor patients prior and after preoperative chemotherapy according to SIOP protocol 2001.

RESULTS:

We did not find a significant difference between miRNA signature of both groups. However both, Wilms tumor patients prior and after chemotherapy showed a miRNA signature different from healthy controls. The signature of Wilms tumor patients prior to chemotherapy showed an accuracy of 97.5% and of patients after chemotherapy an accuracy of 97.0%, each as compared to healthy controls.

CONCLUSION:

Our results provide evidence for a blood-born Wilms tumor miRNA signature largely independent of four weeks preoperative chemotherapy treatment.

• Authors: Jana Schmitt, Christina Backes, Nasenien Nourkami-Tutdibi, Petra Leidinger, Stephanie Deutscher, Markus Beier, Manfred Gessler, Norbert Graf, Hans-Peter Lenhof, Andreas Keller, Eckart Meese
• Journal: BMC genomics (BMC Genomics) Vol. 13 Pg. 379 (Aug 07 2012) ISSN: 1471-2164 [Electronic] England
• PMID: 22871070 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• MicroRNAs

Topics

• Case-Control Studies
• Child, Preschool
• Cluster Analysis
• Humans
• MicroRNAs (blood, genetics)
• Transcriptome (drug effects)
• Wilms Tumor (blood, drug therapy, genetics)